OmniAb Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
OABI$5.10-3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities: | ||
| Net loss | $(48,965) | $(36,566) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 15,977 | 14,563 |
| Share-based compensation | 16,383 | 18,894 |
| Amortization of discounts on short-term investments, net | (1,285) | (2,651) |
| Deferred income taxes, net | (7,223) | (7,467) |
| Change in estimated fair value of contingent liabilities | (2,410) | (275) |
| Other | 524 | 90 |
| Changes in operating assets and liabilities, net: | ||
| Accounts receivable, net | 1,263 | 24,911 |
| Prepaid expenses and other current assets | 341 | 2,312 |
| Other long-term assets | 564 | (134) |
| Accounts payable, accrued expenses, and other liabilities | (3,186) | 1,446 |
| Operating lease liabilities | (1,722) | 380 |
| Deferred revenue | (6,053) | (4,035) |
| Net cash (used in) provided by operating activities | (35,792) | 11,468 |
| Investing activities: | ||
| Purchases of short-term investments | (25,669) | (86,885) |
| Proceeds from the maturity of short-term investments | 63,500 | 66,250 |
| Purchases of property and equipment | (1,829) | (1,537) |
| Payments to contingent liabilities holders | (400) | (3,640) |
| Proceeds from sale of short-term investments | 1,897 | 2,706 |
| Net cash provided by (used in) investing activities | 37,499 | (23,106) |
| Financing activities: | ||
| Payments to contingent liabilities holders | (75) | — |
| Proceeds from issuance of common stock from stock plans | 2,251 | 990 |
| Taxes paid related to net share settlement of equity awards | (960) | (914) |
| Payment of transaction costs | (525) | (472) |
| Proceeds from issuance of common stock under ATM facility, net of commissions | 8,480 | — |
| Net cash provided by (used in) financing activities | 9,171 | (396) |
| Net change in cash, cash equivalents and restricted cash | 10,878 | (12,034) |
| Cash, cash equivalents and restricted cash at beginning of period | 16,918 | 33,839 |
| Cash, cash equivalents and restricted cash at end of period | $27,796 | $21,805 |
| Supplemental cash flow information: | ||
| Deferred revenue recorded in accounts receivable | $892 | $831 |
| Supplemental non-cash investing and financing activities: | ||
| Purchase of fixed assets recorded in accounts payable | $— | $28 |
| Intangible additions recorded in contingent liabilities | $— | $1,376 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.